Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL (Q80148278)
Jump to navigation
Jump to search
scientific article published on 11 April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL |
scientific article published on 11 April 2007 |
Statements
Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL (English)
Amrita V Kamath
Jian Wang
Francis Y Lee
Punit H Marathe
11 April 2007